paltusotine hydrochloride

paltusotine hydrochloride (PALSONIFY) is an FDA-listed pharmaceutical active ingredient. Associated with Crinetics Pharmaceuticals Europe GmbH. Route of administration: oral. Current US regulatory status: approved.

PALSONIFY is a marketed brand name for paltusotine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

paltusotine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.